Is Bloom Energy The Best Stock to Buy Now?
Shares of energy startup Bloom Energy (NYSE:BE) have advanced by…
Sell
49
ULBI Quote, Financials, Valuation and Earnings
Last price:
$5.81
Seasonality move
:
7.71%
Day range:
$5.74 - $6.00
52-week range:
$4.07 - $9.52
Dividend yield:
0%
P/E ratio:
55.78x
P/S ratio:
0.51x
P/B ratio:
0.70x
Volume:
46.3K
Avg. volume:
47.7K
1-year change:
-21.15%
Market cap:
$95.6M
Revenue:
$164.5M
EPS (TTM):
$0.10
Analysts' Opinion
-
Consensus RatingUltralife Corp. has received a consensus rating of Buy. The company's average rating is a Buy based on 1 Buy rating, 0 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $14.00, Ultralife Corp. has an estimated upside of 143.9% from its current price of $5.74.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $14.00 representing 100% downside risk from its current price of $5.74.
Fair Value
-
According to the consensus of 1 analyst, Ultralife Corp. has 143.9% upside to fair value with a price target of $14.00 per share.
ULBI vs. S&P 500
-
Over the past 5 trading days, Ultralife Corp. has underperformed the S&P 500 by -0.28% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Ultralife Corp. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Ultralife Corp. has grown year-over-year revenues for 3 quarters straight. In the most recent quarter Ultralife Corp. reported revenues of $43.4M.
Earnings Growth
-
Ultralife Corp. earnings have been falling on a year-over-year basis for 6 quarters in a row. In the most recent quarter Ultralife Corp. reported earnings per share of -$0.07.
Enterprise value:
140.3M
EV / Invested capital:
--
Price / LTM sales:
0.51x
EV / EBIT:
22.71x
EV / Revenue:
0.75x
PEG ratio (5yr expected):
0.08x
EV / Free cash flow:
15.59x
Price / Operating cash flow:
10.65x
Enterprise value / EBITDA:
12.15x
Gross Profit (TTM):
$43M
Return On Assets:
0.82%
Net Income Margin (TTM):
0.93%
Return On Equity:
1.27%
Return On Invested Capital:
0.95%
Operating Margin:
-2.19%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $150.2M | $165.2M | $186.5M | $35.7M | $43.4M | |
| Gross Profit | $34.9M | $42.2M | $43M | $8.5M | $9.2M | |
| Operating Income | $6M | $12.1M | $6.2M | $511K | -$951K | |
| EBITDA | $10M | $16.1M | $11.5M | $1.5M | $468K | |
| Diluted EPS | $0.25 | $0.54 | $0.10 | $0.02 | -$0.07 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $64.5M | $78.9M | $89.6M | $86.4M | $100.6M | |
| Total Assets | $136.8M | $167.9M | $176.1M | $172.4M | $222.2M | |
| Current Liabilities | $16.7M | $28.1M | $26.4M | $26.2M | $33.7M | |
| Total Liabilities | $18.3M | $52.6M | $54.4M | $37.8M | $84.8M | |
| Total Equity | $118.5M | $115.3M | $121.8M | $134.6M | $137.4M | |
| Total Debt | $2M | $23.9M | $27.2M | $11M | $52.7M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $2.1M | $16M | $12.6M | $4.7M | $174K | |
| Cash From Investing | -$1.8M | -$2.3M | -$51.6M | -$594K | -$991K | |
| Cash From Financing | $4.2M | -$16.1M | $41.6M | -$4M | -$627K | |
| Free Cash Flow | $231K | $13.6M | $9M | $4.1M | -$821K | |
ULBI
Sector
Market Cap
$95.6M
$486.6M
Price % of 52-Week High
60.29%
79.89%
Dividend Yield
0%
0%
Shareholder Yield
-6.73%
1.54%
1-Year Price Total Return
-21.15%
--
Beta (5-Year)
0.876
0.550
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$5.76
200-day SMA
Sell
Level
$6.50
Bollinger Bands (100)
Sell
Level
5.87 - 7.27
Chaikin Money Flow
Sell
Level
-71.1K
20-day SMA
Buy
Level
$5.66
Relative Strength Index (RSI14)
Sell
Level
48.06
ADX Line
Buy
Level
17.82
Williams %R
Neutral
Level
-60
50-day SMA
Sell
Level
$6.13
MACD (12, 26)
Buy
Level
1.09
25-day Aroon Oscillator
Buy
Level
76
On Balance Volume
Sell
Level
-50.9K
Financial Scores
Hold
Altman Z-Score
(Annual)
Level (1.9078)
Buy
CA Score
(Annual)
Level (0.7745)
Buy
Beneish M-Score
(Annual)
Level (-2.839)
Sell
Momentum Score
Level (3)
Buy
Ohlson Score
Level (-0.0737)
Buy
Piotroski F Score
(Annual)
Level (5)
Buy
Quality Ratio Score
Level (6)
Buy
Fundamental Score
Level (7)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Ultralife Corp. engages in the manufacture and sale of products for power solutions. It operates through the Battery & Energy Products and Communications System segments. The Battery & Energy Products segment includes Lithium 9-volt, cylindrical, thin cell and various other non-rechargeable batteries, in addition to rechargeable batteries, uninterruptable power supplies, charging systems, and accessories such as cables. The Communications System segment comprises radio frequency amplifiers, power supplies, cable and connector assemblies, amplified speakers, equipment mounts, case equipment, integrated communication systems for fixed or vehicle applications, and communications and electronics systems design. The company was founded by Arthur M. Liberman in December 1990 and is headquartered in Newark, NY.
Stock Forecast FAQ
In the current month, ULBI has received 1 Buy ratings 0 Hold ratings, and 0 Sell ratings. The ULBI average analyst price target in the past 3 months is $14.00.
-
Where Will Ultralife Corp. Stock Be In 1 Year?
According to analysts, the consensus estimate is that Ultralife Corp. share price will rise to $14.00 per share over the next 12 months.
-
What Do Analysts Say About Ultralife Corp.?
Analysts are divided on their view about Ultralife Corp. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Ultralife Corp. is a Sell and believe this share price will drop from its current level to $14.00.
-
What Is Ultralife Corp.'s Price Target?
The price target for Ultralife Corp. over the next 1-year time period is forecast to be $14.00 according to 1 Wall Street analyst, 1 of them rates the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is ULBI A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Ultralife Corp. is a Buy. 1 of 1 analysts rates the stock a Buy at this time.
-
How Can I Buy Shares Of ULBI?
You can purchase shares of Ultralife Corp. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Ultralife Corp. shares.
-
What Is The Ultralife Corp. Share Price Today?
Ultralife Corp. was last trading at $5.81 per share. This represents the most recent stock quote for Ultralife Corp.. Yesterday, Ultralife Corp. closed at $5.74 per share.
-
How To Buy Ultralife Corp. Stock Online?
In order to purchase Ultralife Corp. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Related Companies
Get ULBI Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
ULBI
Sector
P/E ratio
55.78x
19.09x
PEG ratio
0.08x
0.18x
P/B ratio
0.70x
1.69x
Price / LTM sales
0.51x
0.85x
Growth Metrics
ULBI
Sector
Revenue growth
21.51%
5.02%
Earnings growth
-579.09%
5.88%
Revenue (5-year growth)
9.02%
4.28%
Earnings forecast
$0.14
$0.39
Profitability
ULBI
Sector
Profitability FY 2024
$41.3M
$253.7M
Return on invested capital
0.95%
4.73%
Return on assets
0.82%
3.1%
Return on equity
1.27%
8.14%
Earnings Date
Last Earnings Date
Nov
18
Next Earnings Date
Feb
19
Estimated Next Earnings Date
Feb
17
Balance Sheet
ULBI
Sector
Total cash
$9.3M
$139.8M
Short term investments
--
$32.7M
Total assets
$220.5M
$1.4B
Long term debt
$52.7M
$51.6M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Berkshire Hathaway Stock Undervalued?
Berkshire Hathaway (NYSE:BRK.A,BRK.B) has undershot the market this year, returning…
Is Oracle Stock Undervalued?
Shares of Oracle (NYSE:ORCL) rocketed higher earlier this year when…
Stock Ideas
Buy
54
Is NVDA Stock a Buy?
Market Cap: $4.4T
P/E Ratio: 62x
Buy
53
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
57
Is GOOG Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 38x
Alerts
Sell
1
LW alert for Dec 20
Lamb Weston Holdings, Inc. [LW] is down 25.96% over the past day.
Buy
54
BMRN alert for Dec 20
BioMarin Pharmaceutical, Inc. [BMRN] is up 17.79% over the past day.
Buy
82
RKLB alert for Dec 20
Rocket Lab Corp. [RKLB] is up 17.72% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
